Company Overview and News

Rift Valley Resources to spin drill to expand magnet metal project

Rift Valley Resources Ltd (ASX:RVY) has commenced field exploration programs for 2018 at its 70% owned Ozango Licence in Angola.
Upvote Downvote

Rift Valley Resources stokes up coffers through gold asset sales to pursue Angola interests

Rift Valley Resources Ltd (ASX: RVY) has executed a conditional sale agreement in relation to its Kitongo Gold Project in Tanzania.
Upvote Downvote

Rift Valley receives on-market buying support from two board members

Rift Valley Resources Ltd (ASX:RVY) has had over 2.4 million shares bought on market by two members of its board and management.
Upvote Downvote

Rift Valley Resources receives first batch of copper assays

Rift Valley Resources Ltd (ASX:RVY) has received assays from its 2017 drilling program at the Cassenha Hill Copper Project in Angola.
Upvote Downvote

Rift Valley Resources strengthens board with deal maker

Rift Valley Resources Ltd (ASX:RVY) has appointed investment banker Neil Thacker Maclachlan as a non-executive director to its board of directors.
Upvote Downvote

Rift Valley Resources raises $1.5 million to support exploration in Angola

Rift Valley Resources Ltd (ASX:RVY) will use $1.5 million in placement funds for exploration of its projects in Angola, including the flagship Longonjo Metal Magnet Project.
Upvote Downvote

Rift Valley Resources to boost cash for rare earths in Angola

Rift Valley Resources Ltd (ASX:RVY) is heading to market with a capital raising, and the ASX has granted the company a trading halt to prepare.
Upvote Downvote

Rift Valley Resources reveals positive initial study results for rare earth project

Rift Valley Resources Ltd (ASX:RVY) has received positive initial results from the ongoing scoping study on its 70% owned Longonjo Magnet Metal Project in Angola.
Upvote Downvote

Rift Valley Resources reveals maiden resource for Longonjo Magnet Metals Project in Angola

Rift Valley Resources Ltd’s (ASX:RVY) drilling success has delivered a maiden JORC resource for its 70% owned Longonjo Magnet Metals Project, located in Angola.
Upvote Downvote

CSE: 2017-0407 - Consolidation - Rift Valley Resources Corp. (RVR)

2017-04-12 marketwired
TORONTO, ONTARIO--(Marketwired - April 12, 2017) - Rift Valley Resources Corp. has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post consolidation share for each five (5) pre-consolidation common shares. No fractional shares will be issued. Any fraction of a share equal to or greater than 0.5 common shares will be rounded up to the nearest whole common share and each fractional common share less than 0.
Upvote Downvote

Final Results

2016-09-30 londonstockexchange
Jupiter Energy Limited shares are listed on the Australian Securities Exchange under the code JPR, on the AIM Market under the code JPRL and on the Kazakh Stock Exchange (KASE) under the code AU_JPRL.
Upvote Downvote

Final Results and Notice of AGM

2016-06-06 londonstockexchange
Alecto Minerals plc (AIM: ALO), the Africa-focused gold and base metal exploration and development company, is pleased to announce its audited final results for the year ended 31 December 2015.  In addition, the Company announces that its Annual General Meeting ('AGM') will be held at the Washington Mayfair Hotel, 5 Curzon Street, London, W1J 5HE on 30 June 2016 at 12.00 p.m.  Copies of the Company's Annual Report and Financial Statements, together with the Notice of AGM, will be posted to shareholders today and will shortly be available to view and download on the Company's website at www.
Upvote Downvote

Rift Valley Resources Ltd begins drilling at Tanzanian gold project

Rift Valley Resources Ltd (ASX:RVY) has commenced a reverse circulation drilling program at the company’s 100% owned Miyabi Gold Project in Tanzania. The Miyabi project is an advanced exploration tenement with 704,000 ounces of gold resource at 1.5g/t. The recently completed data migration and geophysical interpretation of the project has identified the potential for repetitions of mineralization within the prospective corridor.
Upvote Downvote

$1.5m Share Placement

Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN:, Inc Analysis and Research Report

2018-04-25 - Asif

Overview opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...